Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at or call 800-767-3771 ext.  9339.

Neogen Corp. (NEOG - Snapshot Report) revealed that it has acquired Pleasantville, Iowa-based manufacturer of animal and food insecticides Chem-Tech Ltd. at an undisclosed price (including contingent payment consideration). NEOG has a long-term association with Chem-Tech as it has used the latter’s Prozap trademark for a number of years for some rodenticides.

Chem-Tech is operating for more than 35 years and is wholly owned by Pat and Kelle Rolfes. Several of its insecticides are approved for use in food establishments. One of its well known brands is Prozap, which is extensively used by dairy and equine producers. Its Turbocide products are also gaining popularity for the fogging of food storage and warehouses.

Most of Chem-Tech’s customers are also the customers of Neogen as both of them have  a long-term relationship. In the last 12 months, Chem-Tech’s revenues amounted to more than $14 million.

In November last year, NEOG also acquired veterinary instrument maker Prima Tech Incorporated. The Kenansville, N.C.-based Prima Tech started its business in 1998 and has become a major supplier of veterinary instruments in the U.S. and major portions of Europe.

Prima Tech’s products are widely used by farmers, ranchers, and veterinarians to inject animals, provide topical applications, as well as for oral administration. They are also used in artificial insemination in the swine industry. Its other products include animal identification and handling equipment.

Neogen reported second quarter fiscal 2014 earnings per share of 17 cents, lagging the Zacks Consensus Estimate of 25 cents by 47% as well as the year-ago earnings of 19 cents by 10.5%. Revenues in the quarter grew 17.4% to $59.5 million, marginally surpassing the Zacks Consensus Estimate of $59.0 million.

Currently, NEOG carries a Zacks Rank #5 (Strong Sell). Some better-ranked stocks in the medical products industry include Advaxis, Inc. (ADXS), diaDexus, Inc. (DDXS), and Hill-Rom Holdings, Inc. (HRC - Snapshot Report). All of them carry a Zacks Rank #2 (Buy).

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GROUP DXYN 15.84 +7.90%
BOFL HOLDING BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%